Cargando…
Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis
PURPOSE: About 15%—40% of gastric cancer patients have peritoneal metastasis, which leads to poor prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) is considered to be an effective treatment for these patients. This study evaluated the efficacy and safety of HIPEC in patients with gastric...
Autores principales: | Wu, Yunzi, Zheng, Xiaohao, Sun, Chunyang, Wang, Shenghui, Ding, Shikang, Wu, Ming, Zhang, Jing, Wang, Bingzhi, Xue, Liyan, Yang, Lin, Tian, Yantao, Xie, Yibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482732/ https://www.ncbi.nlm.nih.gov/pubmed/36115993 http://dx.doi.org/10.1186/s12893-022-01795-6 |
Ejemplares similares
-
Long-term nutritional status after total gastrectomy was comparable to proximal gastrectomy but with much less reflux esophagitis and anastomotic stenosis
por: Ding, Shikang, et al.
Publicado: (2022) -
Dynamic monitoring revealed a slightly prolonged waiting time for total gastrectomy during the COVID-19 pandemic without increasing the short-term complications
por: Zheng, Xiaohao, et al.
Publicado: (2022) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019) -
Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
por: Wu, Tao, et al.
Publicado: (2018) -
Hyperthermic Intraperitoneal Chemotherapy and Recirculation with CO(2): A Safe Technique
por: Gómez-Sanz, Remedios, et al.
Publicado: (2022)